Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients

Young Sang Lyu; Hongyup Ahn; Sangmo Hong; Cheol Young Park

doi:10.2147/DDDT.S512114

Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients

Young Sang Lyu
, Hongyup Ahn
, Sangmo Hong
, Cheol Young Park

Chosun University
Dongguk University
Hanyang University
Kangbuk Samsung Hospital

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	65-66
Number of pages	2
Journal	Drug Design, Development and Therapy
Volume	19
DOIs	https://doi.org/10.2147/DDDT.S512114
State	Published - 2025
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2147/DDDT.S512114

Cite this

@article{6a223ea46d3347adba406e6615b81f88,

title = "Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients",

author = "Lyu, \{Young Sang\} and Hongyup Ahn and Sangmo Hong and Park, \{Cheol Young\}",

year = "2025",

doi = "10.2147/DDDT.S512114",

language = "English",

volume = "19",

pages = "65--66",

journal = "Drug Design, Development and Therapy",

issn = "1177-8881",

publisher = "Dove Medical Press Ltd",

}

TY - JOUR

T1 - Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients

AU - Lyu, Young Sang

AU - Ahn, Hongyup

AU - Hong, Sangmo

AU - Park, Cheol Young

PY - 2025

Y1 - 2025

UR - https://www.scopus.com/pages/publications/85215374525

U2 - 10.2147/DDDT.S512114

DO - 10.2147/DDDT.S512114

M3 - Letter

C2 - 39803608

AN - SCOPUS:85215374525

SN - 1177-8881

VL - 19

SP - 65

EP - 66

JO - Drug Design, Development and Therapy

JF - Drug Design, Development and Therapy

ER -

Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients

UN SDGs

Access to Document

Other files and links

Cite this